Monday, 8 August, 2022
TopicPharmaceuticals

Topic: Pharmaceuticals

Angry chemists threaten to boycott Cipla products if it ventures into e-pharmacy business

Over 8.5 lakh chemists say they will ‘sideline’ and ‘stop promoting’ Cipla if reports of its tie-up with online pharmacy Medlife turn out to be true.

Now, an oral drug to treat deadly kala-azar — IIT Hyderabad says it’s faster, better

Researchers at IIT Hyderabad say the pills will ensure controlled release of the drug used to treat the disease, bettering a patient's chance of survival.

After giant pharma push, China keeps Indian drug makers waiting

It was in July last year that the Chinese government had reached an agreement on reducing tariffs on the import of Indian medicines.

Modi govt likely to ban 80 more ‘irrational’ drug cocktails by next month

The medicines that could be banned are antibiotics Orflaz, Nuforce 3 kit and Vaginobact, and hypertension drugs Telipril H and Ramtel H.

Nobel 2018 for medicine & chemistry is great news for science, but probably not patients

The pharma industry needs to do a better job of grappling with how success tends to bring out its worst instincts.

A needle in the eye promises improved treatment for blinding glaucoma

Projected to affect about 80 million people by 2020, the condition causes progressive loss of peripheral vision which ultimately leads to blindness.

Next blockbuster drugs should include existing ones

A growing crop of research, including a New England Journal of Medicine study, suggests there are gains to be made by better using drugs we already have.

Indian pharma firms lukewarm on China’s lowered drug tariffs considering lengthy approvals

The announcement was made to provide opening to Indian pharmaceutical firms to market their economically priced drugs.

Patanjali is under the scanner once again for ‘post-dating’ their products

According to Facebook and Twitter users, boxes of the ayurvedic product that bore a ‘May 2018’ manufacturing date were found on counters in April.

India’s import of China-made medicines has increased 50 per cent in 4 years

The export of pharmaceuticals, especially generics and drug formulations, is one of India’s strengths. But China has been steadily eroding India’s advantage.

On Camera

YourTurn

Opposition leaders protest outside Parliament | Representative image | ANI

Confused, aimless—why Opposition parties live up to Ronen Sen’s ‘headless chicken’ remark

From ‘compromising national security’ to 'playing havoc' with institutions, the Opposition continues to attack Modi while failing to reflect on own actions.
A suspension pylon in Tamil Nadu | Commons

You thought power subsidy is a Delhi-Punjab problem? Check out Tamil Nadu’s power sector mess

RBI data shows Indian discoms owe power generation firms over Rs 4.5 lakh crore, almost a third of which is owed by Tamil Nadu, where power subsidy cost is twice that of food subsidy.

Defence

The Flying Dolphin — how a former Indian Navy submariner qualified as a commercial pilot 

Vivek Chaudhary retired from the Indian Navy in 2017 after serving on the  Short-Service Commission. After that, his dreams took flight. 

In Kashmir 3 years on, 3 positive changes, 3 things that should’ve happened & 3 that got worse

Kashmir as a crisis has fallen off our headlines and from the top of our collective minds. Which is precisely the most important change for the better.
×